Latexin (LXN) Antikörper
| Antigen |
|
| Synonyme |
ECI, TCI, MGC144352, MGC144353, MGC93322, wu:fk66c02, LXN, MGC142553, lxn |
| Klonalität |
Polyklonal |
|
Wirt
|
|
|
Reaktivität
|
|
|
Applikation
|
|
| Produktnummer |
ABIN190839 |
| Menge |
100 ug |
| Preis |
286,00 € Zzgl. Versandkosten €40,00 und MWSt
|
| Lieferung nach |
|
| Verfügbarkeit |
Lieferung in 5 Werktagen |
|
Weitere Bezeichnung
|
Latexin
|
|
Gen-ID
|
56925, 17035 (mouse), 59073 (rat)
|
|
Immunogen
|
C-QYGTKVKHNSRLPKE
|
|
Format
|
Affinity-purified
|
|
Beschreibung
|
All names and symbols: latexin, latexin protein, LXN, ECI, TCI. Official Symbol: LXN. RefSeq number(s): NP_064554.2
|
|
Spezifität
|
Human, Mouse, Rat, Dog
|
|
Applikationshinweise
|
Peptide ELISA: antibody detection limit dilution 1:128,000. Western Blot: Approx 30kDa band observed in lysates of Human Brain (Cerebellum), Mouse Brain and Rat Brain (calculated MW of 25.8kDa according to NP_064554.2). Recommended concentration: 1-3µg/ml.
|
|
Reinigung
|
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
|
|
Buffer
|
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
|
|
Lagerung
|
Aliquot and store at -20°C. Minimize freezing and thawing.
|
|
Beschränkungen
|
Nur für Forschungszwecke einsetzbar
|
|
Publikationen
|
de Haan: "Latexin is a newly discovered regulator of hematopoietic stem cells." in: Nature genetics, Vol. 39, Issue 2, pp. 141-2, 2007 (PubMed).
|
Alternativen zu Antigen "Latexin (LXN)", Typ "Antikörper" finden
|
Wirte
|
Kaninchen (10), Ziege (4), Huhn (2), Maus (1)
|
|
Reaktivitäten
|
Human (14), Ratte (Rattus) (4), Maus (3), Hund (2)
|
|
Applikationen
|
Western Blot (WB) (15), Enzyme Immunoassay (EIA) (10), Immunhistochemie (Paraffinschnitte) (IHC (p)) (6), Immunfluoreszenz (IF) (3), ELISA (2), Immunhistochemie (Gefrierschnitte) (IHC (fro)) (2), Immunhistochemie (IHC) (2), ELISA (Detektionsantikörper) (1), Durchflusszytometrie (FACS) (1)
|
|
Epitope
|
N-Term (3), Center (2), C-Term (1)
|